Published in Oncogene on January 01, 1990
Molecular biology of breast cancer metastasis. Inflammatory breast cancer: clinical syndrome and molecular determinants. Breast Cancer Res (2000) 2.13
Estrogen receptor alpha controls a gene network in luminal-like breast cancer cells comprising multiple transcription factors and microRNAs. Am J Pathol (2010) 1.73
Inflammatory breast cancer: what we know and what we need to learn. Oncologist (2012) 1.41
The mouse one P-domain (pS2) and two P-domain (mSP) genes exhibit distinct patterns of expression. J Cell Biol (1993) 1.41
Mechanism of and requirement for estrogen-regulated MYB expression in estrogen-receptor-positive breast cancer cells. Proc Natl Acad Sci U S A (2007) 1.27
Expression of Slug is regulated by c-Myb and is required for invasion and bone marrow homing of cancer cells of different origin. J Biol Chem (2010) 1.16
Identification and regulation of c-Myb target genes in MCF-7 cells. BMC Cancer (2011) 1.13
Expression of cyclophilin B is associated with malignant progression and regulation of genes implicated in the pathogenesis of breast cancer. Am J Pathol (2008) 1.00
MYB suppresses differentiation and apoptosis of human breast cancer cells. Breast Cancer Res (2010) 0.99
c-Myb regulates matrix metalloproteinases 1/9, and cathepsin D: implications for matrix-dependent breast cancer cell invasion and metastasis. Mol Cancer (2012) 0.98
Potential tumor suppressor role for the c-Myb oncogene in luminal breast cancer. PLoS One (2010) 0.95
Role of c-Myb during prolactin-induced signal transducer and activator of transcription 5a signaling in breast cancer cells. Endocrinology (2008) 0.94
Activation of miR200 by c-Myb depends on ZEB1 expression and miR200 promoter methylation. Cell Cycle (2013) 0.93
Prdm14 initiates lymphoblastic leukemia after expanding a population of cells resembling common lymphoid progenitors. Oncogene (2011) 0.91
Demystified ... oncogenes. Mol Pathol (1999) 0.87
Estrogen receptor-α recruits P-TEFb to overcome transcriptional pausing in intron 1 of the MYB gene. Nucleic Acids Res (2012) 0.86
Oestrogen and growth factor cross-talk and endocrine insensitivity and acquired resistance in breast cancer. Br J Cancer (2000) 0.85
The current understanding of the molecular determinants of inflammatory breast cancer metastasis. Clin Exp Metastasis (2006) 0.84
Cell cycle dependent oscillatory expression of estrogen receptor-α links Pol II elongation to neoplastic transformation. Proc Natl Acad Sci U S A (2014) 0.82
Myb proteins inhibit fibroblast transformation by v-Rel. Mol Cancer (2006) 0.78
The Major Prognostic Features of Nuclear Receptor NR5A2 in Infiltrating Ductal Breast Carcinomas. Int J Genomics (2015) 0.77
Induction of stable drug resistance in human breast cancer cells using a combinatorial zinc finger transcription factor library. PLoS One (2011) 0.77
CDK9 inhibitors selectively target estrogen receptor-positive breast cancer cells through combined inhibition of MYB and MCL-1 expression. Oncotarget (2016) 0.76
The chicken miR-150 targets the avian orthologue of the functional zebrafish MYB 3'UTR target site. BMC Mol Biol (2010) 0.75
The Myb-p300 Interaction Is a Novel Molecular Pharmacologic Target. Mol Cancer Ther (2015) 0.75
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion. Proc Natl Acad Sci U S A (1992) 3.27
Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors. Proc Natl Acad Sci U S A (1995) 2.56
Characterization of a human ovarian adenocarcinoma line, IGROV1, in tissue culture and in nude mice. Cancer Res (1985) 2.06
Complete nucleotide sequence of minicircle kinetoplast DNA from Trypanosoma equiperdum. Proc Natl Acad Sci U S A (1981) 1.56
Generating high-current monoenergetic proton beams by a circularly polarized laser pulse in the phase-stable acceleration regime. Phys Rev Lett (2008) 1.51
Electron microscopy of the circular kinetoplastic DNA from Trypanosoma cruzi: occurrence of catenated forms. Proc Natl Acad Sci U S A (1969) 1.49
Structure and expression of c-erbB-2 and EGF receptor genes in inflammatory and non-inflammatory breast cancer: prognostic significance. Int J Cancer (1989) 1.35
Cancer risk in heterozygotes for ataxia-telangiectasia. Int J Cancer (2001) 1.32
Preparation and properties of nuclear and satellite deoxyribonucleic acid of Trypanosoma cruzi. J Mol Biol (1967) 1.31
Daunorubicin-induced apoptosis: triggering of ceramide generation through sphingomyelin hydrolysis. EMBO J (1996) 1.31
Breast cancer risk in ataxia telangiectasia (AT) heterozygotes: haplotype study in French AT families. Br J Cancer (1999) 1.30
Replicating, convalently closed, circular DNA from kinetoplasts of Trypanosoma cruzi. Proc Natl Acad Sci U S A (1972) 1.23
ATP-independent type II topoisomerase from trypanosomes. Proc Natl Acad Sci U S A (1986) 1.16
Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis. Oncogene Res (1988) 1.16
Somatic deletions and mutations of c-Ha-ras gene in human cervical cancers. Oncogene (1988) 1.11
Purification and characterization of Plasmodium berghei DNA topoisomerases I and II: drug action, inhibition of decatenation and relaxation, and stimulation of DNA cleavage. Biochemistry (1986) 1.11
Correlation of MDR1 gene expression with chemotherapy in neuroblastoma. J Natl Cancer Inst (1989) 1.08
Phospholipase A2 is necessary for tumor necrosis factor alpha-induced ceramide generation in L929 cells. J Biol Chem (1997) 1.08
Genetic heterogeneity in ductal carcinoma of the breast. Lab Invest (2000) 1.08
C-myc proto-oncogene expression and prognosis in early carcinoma of the uterine cervix. Lancet (1987) 1.08
Expression of a human multidrug resistance gene in ovarian carcinomas. Cancer Res (1989) 1.06
Absence of kinetoplast DNA in a late antigenic variant of Trypanosoma equiperdum. Mol Biochem Parasitol (1980) 1.06
Re-evaluation of "reactive lymphoid hyperplasia of the uvea": an immunohistochemical and molecular analysis of 10 cases. Ophthalmology (2000) 1.03
Abnormal circular DNA molecules induced by ethidium bromide in the kinetoplast of Trypanosoma cruzi. Proc Natl Acad Sci U S A (1969) 1.02
[Fractionation and characterization of desoxyribonucleic acid (DNA) of trypanosomes (Trypanosoma equiperdum)]. C R Acad Sci Hebd Seances Acad Sci D (1966) 1.00
The sphingomyelin-ceramide signaling pathway is involved in oxidized low density lipoprotein-induced cell proliferation. J Biol Chem (1996) 0.97
Occurrence of a kinetoplast DNA-protein complex in Trypanosoma cruzi. Biochem Biophys Res Commun (1981) 0.97
Doxorubicin induces slow ceramide accumulation and late apoptosis in cultured adult rat ventricular myocytes. Cardiovasc Res (1999) 0.96
Loss of heterozygosity, allele silencing and decreased expression of p73 gene in breast cancers: prevalence of alterations in inflammatory breast cancers. Oncogene (2000) 0.96
Cancer risk according to type and location of ATM mutation in ataxia-telangiectasia families. Genes Chromosomes Cancer (2005) 0.96
[Induction of a "dyskinetoplast" by ethidium bromide in Trypanosoma cruzi cultivated in vitro]. C R Acad Sci Hebd Seances Acad Sci D (1967) 0.94
Combined analysis of DNA ploidy index and N-myc genomic content in neuroblastoma. Cancer Res (1991) 0.93
Intense high-contrast femtosecond K-shell x-ray source from laser-driven Ar clusters. Phys Rev Lett (2010) 0.93
Coactivation of the MDR1 and MYCN genes in human neuroblastoma cells during the metastatic process in the nude mouse. Cancer Res (1994) 0.93
Analysis of the c-Ha-ras-1 gene for deletion, mutation, amplification and expression in lymph node metastases of human head and neck carcinomas. Br J Cancer (1990) 0.93
c-myc, p53 and bcl-2, apoptosis-related genes in infiltrating breast carcinomas: evidence of a link between bcl-2 protein over-expression and a lower risk of metastasis and death in operable patients. Int J Cancer (1999) 0.92
Definition of regions of the human genome affected by loss of heterozygosity in primary human breast tumors. J Cell Biochem Suppl (1993) 0.92
Enhanced sensitivity with a novel TCRgamma PCR assay for clonality studies in 569 formalin-fixed, paraffin-embedded (FFPE) cases. Mol Diagn (1999) 0.92
[Study of kinetoplast DNA of Trypansoma cruzi using restriction endonucleases]. C R Acad Sci Hebd Seances Acad Sci D (1975) 0.90
c-erbB2 gene amplification and protein expression in ovarian epithelial tumors: evaluation of their respective prognostic significance by multivariate analysis. Int J Cancer (1995) 0.90
Study of x-ray emission enhancement via a high-contrast femtosecond laser interacting with a solid foil. Phys Rev Lett (2008) 0.89
Ultrastructural alterations of Trypanosoma cruzi kinetoplast induced by the interaction of a trypanocidal drug (hydroxystilbamidine) with the kinetoplast DNA. J Ultrastruct Res (1971) 0.89
ATP-independent DNA topoisomerase II as potential drug target in trypanosomes. Biol Cell (1988) 0.89
Detection of interaction involving identified genes: available study designs. J Natl Cancer Inst Monogr (1999) 0.89
In vivo stimulation by antitumor drugs of the topoisomerase II induced cleavage sites in c-myc protooncogene. Biochem Biophys Res Commun (1986) 0.89
Molecular organization of the kinetoplast DNA of Trypanosoma cruzi treated with berenil, a DNA interacting drug. J Ultrastruct Res (1972) 0.89
Bright betatron X-ray radiation from a laser-driven-clustering gas target. Sci Rep (2013) 0.88
[DNA ultrastructure of the kinetoplast of Trypanosoma cruzi cultivated in vitro]. C R Acad Sci Hebd Seances Acad Sci D (1969) 0.88
[Presence of papillomavirus genomes and amplification of the c-myc and C-Ha-ras oncogenes in invasive cancers of the uterine cervix]. C R Acad Sci III (1984) 0.88
Circular oligomers in mitochondrial DNA of human and beef nonmalignant thyroid glands. Proc Natl Acad Sci U S A (1972) 0.88
Near-complete absorption of intense, ultrashort laser light by sub-lambda gratings. Phys Rev Lett (2008) 0.87
The transmission probability model is useful to prevent false inference. Am J Hum Genet (1993) 0.87
Sequential modifications of topoisomerase I activity in a camptothecin-resistant cell line established by progressive adaptation. Biochem Pharmacol (1993) 0.87
Prognostic value of c-myc proto-oncogene overexpression in early invasive carcinoma of the cervix. J Clin Oncol (1990) 0.86
Structure and expression of c-myc and c-fos proto-oncogenes in thyroid carcinomas. Br J Cancer (1988) 0.86
Association of c-erbB2-gene amplification with poor prognosis in non-inflammatory breast carcinomas but not in carcinomas of the inflammatory type. Int J Cancer (1994) 0.85
N-myc genomic content and DNA ploidy in stage IVS neuroblastoma. J Clin Oncol (1991) 0.85
[Ultrastructure of DNA alterations of Trypanosoma cruzi kinetoplasts treated with ethidium bromide]. C R Acad Sci Hebd Seances Acad Sci D (1969) 0.84
Nuclear and kinetoplastic DNA from trypanosomes. J Protozool (1969) 0.84
Ultrashort electron pulses as a four-dimensional diagnosis of plasma dynamics. Rev Sci Instrum (2010) 0.84
Study of molecular markers of resistance to m-AMSA in a human breast cancer cell line. Decrease of topoisomerase II and increase of both topoisomerase I and acidic glutathione S transferase. Biochem Pharmacol (1991) 0.84
Primary graft failure : a clinicopathologic and molecular analysis. Ophthalmology (2000) 0.84
Expression of MDR1 and GST pi genes in 35 advanced neuroblastomas. Prog Clin Biol Res (1991) 0.84
[Mitochondrial DNA of malignant cells]. Bull Cancer (1971) 0.84
Analysis of topoisomerase II-mediated DNA cleavage of the c-myc gene during HL60 differentiation. FEBS Lett (1993) 0.84
Restriction cleavage map of kinetoplast DNA minicircles from Trypanosoma equiperdum. Biochem Biophys Res Commun (1979) 0.84
Inhibitors of trypanosome topoisomerases. Biochem Soc Trans (1986) 0.83
Oral contraceptives and breast cancer: a French case-control study. Int J Epidemiol (1991) 0.83
Stimulation of the topoisomerase II induced DNA cleavage sites in the c-myc protooncogene by antitumor drugs is associated with gene expression. Biochemistry (1989) 0.83
Topoisomerase II-mediated DNA cleavage activity induced by ellipticines on the human tumor cell line N417. Biochem Pharmacol (1989) 0.83
Demonstration of bulk acceleration of ions in ultraintense laser interactions with low-density foams. Phys Rev E Stat Nonlin Soft Matter Phys (2005) 0.83
Berenil induces the complete loss of kinetoblast DNA sequences in Trypanosoma equiperdum. Biochem Biophys Res Commun (1980) 0.83
Mutation and abnormal expression of the p53 gene in the viral skin carcinogenesis of epidermodysplasia verruciformis. J Invest Dermatol (2001) 0.82
[Inhibition by ellipticine derivatives of the reactions catalysed by the topoisomerases: preferential inhibition of topoisomerase II]. C R Seances Acad Sci III (1983) 0.82
Cisplatin-induced apoptosis and p53 gene status in a cisplatin-resistant human ovarian carcinoma cell line. Int J Cancer (1996) 0.82
Mitochondrial DNA from cells transformed by Avian myeloblastosis virus. Biochimie (1971) 0.82
p53 mediated tumor cell response to chemotherapeutic DNA damage: a preliminary study in matched pairs of breast cancer biopsies. Hum Pathol (1995) 0.82
Over-expression of MDR1 gene with no DNA amplification in a multiple-drug-resistant human ovarian carcinoma cell line. Int J Cancer (1989) 0.81
Candidate target genes for loss of heterozygosity on human chromosome 17q21. Br J Cancer (2004) 0.81
Enhanced collimated GeV monoenergetic ion acceleration from a shaped foil target irradiated by a circularly polarized laser pulse. Phys Rev Lett (2009) 0.81
Isolation and characterization of circular DNA molecules heterogeneous in size from a dyskinetoplastic strain of Trypanosoma equiperdum. Biochem Biophys Res Commun (1977) 0.81
Specific inhibition by ethidium bromide of the incorporation of 3 H thymidine into the kinetoplastic DNA of Trypanosoma cruzi. Biochem Pharmacol (1970) 0.80
c-Ha-ras-1 polymorphism in human breast carcinomas: evidence for a normal distribution of alleles. Oncogene Res (1988) 0.80
Expression of the human fetal bac h19 gene in invasive cancers. Int J Oncol (1993) 0.80
Laser shaping of a relativistic intense, short Gaussian pulse by a plasma lens. Phys Rev Lett (2011) 0.80
[Buschke-Löwenstein tumor. 3 vulvar localizations. Association with HPV-6 in one case]. Ann Dermatol Venereol (1985) 0.79
Observation of a fast electron beam emitted along the surface of a target irradiated by intense femtosecond laser pulses. Phys Rev Lett (2006) 0.79
Three-dimensional particle-in-cell simulations of energetic electron generation and transport with relativistic laser pulses in overdense plasmas. Phys Rev E Stat Nonlin Soft Matter Phys (2002) 0.79
Degradation of fluorescent and radiolabelled sphingomyelins in intact cells by a non-lysosomal pathway. Biochim Biophys Acta (1995) 0.79
[Disappearance of DNA from the kinetoplast of Trypanosoma Cruzi cultivated in the presence of ethidium bromide]. C R Acad Sci Hebd Seances Acad Sci D (1968) 0.79
[Trypanocidal activity of some ellipticine derivatives against Trypanosoma cruzi cultured in vitro]. C R Acad Sci Hebd Seances Acad Sci D (1975) 0.79
Tumorigenicity of cerebellar primitive neuro-ectodermal tumors in athymic mice correlates with poor prognosis in children. Int J Cancer (1996) 0.78
Characterization by sedimentation analysis of kinetoplast DNA from Trypanosoma cruzi at different stages of culture. Nucleic Acids Res (1979) 0.78
Generation of quasi-monoenergetic electron beams with small normalized divergences angle from a 2 TW laser facility. Opt Express (2014) 0.78